Supplementation with the probiotic Bifidobacterium lactis BB-12 improves the efficacy of alendronate sodium/vitamin D₃ therapy on skeletal health in stage 3 CKD - PubMed
3 hours ago
- #Chronic Kidney Disease
- #Bone Health
- #Probiotics
- Supplementation with probiotic Bifidobacterium lactis BB-12 enhances the effectiveness of alendronate sodium/vitamin D therapy for skeletal health in stage 3 chronic kidney disease (CKD).
- The study involves keywords including bone mineral density, chronic kidney disease, elderly, gut microbiota, osteoporosis, probiotics, and T cell metabolism.
- The authors declare no personal, financial, commercial, or academic conflicts of interest.